semaglutide non responder Why Some Patients Do Not Respond to GLP-1 Therapies Why weight‑loss drugs don't work

Okumura Y, Sugiyama T

Understanding these distinctions is essential for patients with type 2 diabetes and healthcare providers navigating treatment decisions in an era of widespread supplement marketing and misinformation

TMEFF1 is expressed specifically in neurons of the central nervous system and is not regulated by type I interferon, the best-known innate antiviral system controlling virus infections

Supports the regulation of sleep cycles and circadian rhythm

Patient suitability should be assessed by the treating professional, with caution in anyone with known hypersensitivity to L-carnitine and in pregnancy or breastfeeding unless directed by a physician